Refine Results
  1. "Ross Levine"
Formats
  1. Journal Article (334)
  2. Meeting Abstract (266)
  3. Review (12)
  4. Editorial (8)
  5. Research Letter (6)
  6. Book Section (3)
  7. Conference Paper (2)
  8. Book Whole (1)
  9. Guidelines (1)
Groups
  1. Adult Leukemia (633)
  2. Center for Hematologic Malignancies (633)
  3. Department of Medicine (633)
  4. Executive Committee, Center for Hematologic Malignancies (633)
  5. GSK Faculty (633)
  6. Hematologic Malignancies, Division of (633)

More Groups

People
  1. Ross Levine (633)
  2. Omar Abdel-Wahab (153)
  3. Martin Tallman (113)
  4. Raajit Rampal (76)
  5. Jay Patel (52)
  6. Alan Shih (48)

More People

Years
  1. 2022 (8)
  2. 2021 (32)
  3. 2020 (46)
  4. 2019 (53)
  5. 2018 (55)
  6. 2017 (38)

More Years

Publications
  1. Blood (222)
  2. Leukemia (31)
  3. Cancer Research (25)
  4. Haematologica (24)
  5. Cancer Cell (20)
  6. Cancer Discovery (16)

More Publications

Publishers
  1. American Society of Hematology (235)
  2. Nature Publishing Group (89)
  3. American Association for Cancer Research (55)
  4. Cell Press (44)
  5. Ferrata Storti Foundation (24)
  6. Elsevier Inc. (20)

More Publishers

Results (633)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The CXCR1/CXCR2 inhibitor reparixin alters the development of myelofibrosis in the Gata1(low) mice
    Journal Article

    Verachi, P.; Gobbo, F.; Martelli, F.; Martinelli, A.; Sarli, G.; Dunbar, A.; Levine, R. L.; Hoffman, R.; Massucci, M. T.; Brandolini, L.; more...
    Frontiers in Oncology (2022)

    Fulltext@MSK | Save
  • Unlocking the secrets to Janus kinase activation
    Editorial

    Levine, R. L.; Hubbard, S. R.
    Science (2022)

    Fulltext@MSK | Save
  • Targeting mutations in cancer
    Journal Article

    Waarts, M. R.; Stonestrom, A. J.; Park, Y. C.; Levine, R. L.
    Journal of Clinical Investigation (2022)

    Fulltext@MSK | Save
  • Bone marrow surveillance of pediatric cancer survivors identifies clones that predict therapy-related leukemia
    Journal Article

    Spitzer, B.; Rutherford, K. D.; Gundem, G.; McGovern, E. M.; Millard, N. E.; Arango Ossa, J. E.; Cheung, I. Y.; Gao, T.; Levine, M. F.; Zhang, Y.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Guiding the global evolution of cytogenetic testing for hematologic malignancies
    Guidelines

    Akkari, Y. M. N.; Baughn, L. B.; Dubuc, A. M.; Smith, A. C.; Mallo, M.; Dal Cin, P.; Diez Campelo, M.; Gallego, M. S.; Granada Font, I.; Haase, D. T.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • The hematopoietic saga of clonality in sickle cell disease
    Journal Article

    Stonestrom, A. J.; Levine, R. L.
    Journal of Clinical Investigation (2022)

    Fulltext@MSK | Save
  • Reduced plasmacytoid dendritic cell output is associated with high risk in low-grade myelodysplastic syndrome
    Research Letter

    Chan, A.; Liu, Y.; Devlin, S.; Gao, Q.; Baik, J.; Sigler, A.; Londono, D.; Arcila, M.; Levine, R.; Dogan, A.; more...
    HemaSphere (2022)

    Fulltext@MSK | Save
  • ASXL1 loss cooperates with oncogenic NRAS in mice to reprogram the immune microenvironment and drive leukemic transformation
    Journal Article

    You, X.; Liu, F.; Binder, M.; Vedder, A.; Lasho, T.; Wen, Z.; Gao, X.; Flietner, E.; Rajagopalan, A.; Zhou, Y.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Resistance to type II JAK2 inhibition in MPN is dependent on chromatin remodeling and MAPK activation and is targetable
    Meeting Abstract

    Szybinski, J.; Codilupi, T.; Stivala, S.; Brkic, S.; Yang, J. L.; Wicki, A.; Ghosh, N.; Passweg, J.; Dirnhofer, S.; Levine, R. L.; more...
    Swiss Medical Weekly (2021)

    Fulltext@MSK | Save
  • Lysine acetylation restricts mutant IDH2 activity to optimize transformation in AML cells
    Journal Article

    Chen, D.; Xia, S.; Zhang, R.; Li, Y.; Famulare, C. A.; Fan, H.; Wu, R.; Wang, M.; Zhu, A. C.; Elf, S. E.; more...
    Molecular Cell (2021)

    Fulltext@MSK | Save